MacReport.Net, Inc. (MRPT)
USD 0.04
(-47.44%)
USD 0.04
(-47.44%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2006 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -4000.00 | -12.4 Thousand | 55.2 Thousand | 55.2 Thousand | 55.2 Thousand | -96.4 Thousand |
| Net Income | -3800.00 | -33.2 Thousand | -31.1 Thousand | -29.1 Thousand | -29.1 Thousand | -310.21 Thousand |
| Depreciation & Amortization | - | 27.6 Thousand | 27.6 Thousand | 27.6 Thousand | 27.6 Thousand | 6089.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -200.00 | -6800.00 | 3500.00 | 1500.00 | 1500.00 | 72.52 Thousand |
| Other non-cash items | - | 55.2 Thousand | 55.2 Thousand | 55.2 Thousand | 55.2 Thousand | 142.33 Thousand |
| Investing Cash Flow | - | - | - | - | - | -1429.00 |
| Investments in PPE | - | - | - | - | - | -2704.00 |
| Acquisitions | - | - | - | - | - | 1300.00 |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | -25.00 |
| Financing Cash Flow | 4000.00 | 12.4 Thousand | - | - | - | 102.26 Thousand |
| Debt repayment | -4000.00 | -12.4 Thousand | - | - | - | -18.29 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | 83.97 Thousand |
| Other Financing Activities | 8000.00 | - | - | - | - | - |
| Accounts receivables | - | - | - | - | - | -51.88 Thousand |
| Accounts payables | - | - | - | - | - | 102.69 Thousand |
| Inventory | - | - | - | - | - | -45.77 Thousand |
| Other working capital | -200.00 | -6800.00 | 3500.00 | 1500.00 | 1500.00 | 67.49 Thousand |
| Cash at beginning of period | - | - | - | - | - | 32.69 Thousand |
| Cash at end of period | - | - | 55.2 Thousand | 55.2 Thousand | 55.2 Thousand | 4977.00 |
| Capital Expenditure | - | - | - | - | - | -2704.00 |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | 55.2 Thousand | 55.2 Thousand | 55.2 Thousand | -27.71 Thousand |
| Free Cash Flow | -4000.00 | -12.4 Thousand | 55.2 Thousand | 55.2 Thousand | 55.2 Thousand | -99.1 Thousand |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -800.00 | -1000.00 | -3800.00 | -800.00 | -1000.00 | -1000.00 |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -200.00 | 1000.00 | -200.00 | -1000.00 | - | -200.00 |
| Other non-cash items | -0.20 | - | - | - | - | -0.20 |
| Investing Cash Flow | - | - | - | - | - | 138 Thousand |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | 138 Thousand |
| Financing Cash Flow | 1000.00 | - | 4000.00 | 1800.00 | 1000.00 | 1200.00 |
| Debt repayment | -1000.00 | - | -4000.00 | -1800.00 | -1000.00 | -1200.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | 8000.00 | 3600.00 | 2000.00 | 2400.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -200.00 | - | - | - | - | -200.00 |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | 1000.00 | -200.00 | -1000.00 | - | - |
| Cash at beginning of period | - | - | - | - | - | - |
| Cash at end of period | - | - | - | - | - | 138 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | - | - | - | 138 Thousand |
| Free Cash Flow | -1000.00 | - | -4000.00 | -1800.00 | -1000.00 | -1200.00 |
AYYLF
PHYT
600835
688682
NNRI
SIOPF